(Q40411040)

20 September 2017

1 reference

title

The role of gp39 (CD40L) in immunity (English)

1 reference

20 September 2017

Noelle RJ

1

1 reference

20 September 2017

publication date

1 September 1995

1 reference

Clinical Immunology and Immunopathology

20 September 2017

published in

1 reference

20 September 2017

volume

76

1 reference

20 September 2017

issue

3 Pt 2

1 reference

20 September 2017

page(s)

S203-7

1 reference

Membranes of activated CD4+ T cells expressing T cell receptor (TcR) alpha beta or TcR gamma delta induce IgE synthesis by human B cells in the presence of interleukin-4

20 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0090-1229%2895%2990234-1

7 January 2021

The CD40 antigen and its ligand

1 reference

https://api.crossref.org/works/10.1016%2FS0090-1229%2895%2990234-1

7 January 2021

Molecular and biological characterization of a murine ligand for CD40

1 reference

https://api.crossref.org/works/10.1016%2FS0090-1229%2895%2990234-1

7 January 2021

The CD40 ligand, gp39, is defective in activated T cells from patients with X-linked hyper-IgM syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0090-1229%2895%2990234-1

7 January 2021

CD40 Ligand Gene Defects Responsible for X-Linked Hyper-IgM Syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0090-1229%2895%2990234-1

7 January 2021

Defective expression of T-cell CD40 ligand causes X-linked immunodeficiency with hyper-IgM

1 reference

https://api.crossref.org/works/10.1016%2FS0090-1229%2895%2990234-1

7 January 2021

CD40 ligand mutations in X-linked immunodeficiency with hyper-IgM

1 reference

https://api.crossref.org/works/10.1016%2FS0090-1229%2895%2990234-1

7 January 2021

In vivo CD40-gp39 interactions are essential for thymus-dependent humoral immunity. II. Prolonged suppression of the humoral immune response by an antibody to the ligand for CD40, gp39

1 reference

https://api.crossref.org/works/10.1016%2FS0090-1229%2895%2990234-1

7 January 2021

Memory B cell development but not germinal center formation is impaired by in vivo blockade of CD40-CD40 ligand interaction

1 reference

https://api.crossref.org/works/10.1016%2FS0090-1229%2895%2990234-1

7 January 2021

Mice deficient for the CD40 ligand

1 reference

https://api.crossref.org/works/10.1016%2FS0090-1229%2895%2990234-1

7 January 2021

The immune responses in CD40-deficient mice: impaired immunoglobulin class switching and germinal center formation

1 reference

https://api.crossref.org/works/10.1016%2FS0090-1229%2895%2990234-1

7 January 2021

In vivo CD40-gp39 interactions are essential for thymus-dependent humoral immunity. I. In vivo expression of CD40 ligand, cytokines, and antibody production delineates sites of cognate T-B cell interactions

1 reference

https://api.crossref.org/works/10.1016%2FS0090-1229%2895%2990234-1

7 January 2021

Identification of a source of biologically active CD40 ligand

1 reference

https://api.crossref.org/works/10.1016%2FS0090-1229%2895%2990234-1

7 January 2021

Selective development of CD4+ T cells in transgenic mice expressing a class II MHC-restricted antigen receptor

1 reference

https://api.crossref.org/works/10.1016%2FS0090-1229%2895%2990234-1

7 January 2021

Small B cells as antigen-presenting cells in the induction of tolerance to soluble protein antigens

1 reference

https://api.crossref.org/works/10.1016%2FS0090-1229%2895%2990234-1

7 January 2021

In vivo and in vitro clonal deletion of double-positive thymocytes

1 reference

https://api.crossref.org/works/10.1016%2FS0090-1229%2895%2990234-1

7 January 2021

10.1016/S0090-1229(95)90234-1

Identifiers

DOI

1 reference

20 September 2017

1 reference